ACP journal club. Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs. Article uri icon

Overview

publication date

  • March 17, 2015

Research

keywords

  • Anticoagulants
  • Critical Illness
  • Dalteparin
  • Health Expenditures
  • Heparin
  • Venous Thromboembolism

Identity

Scopus Document Identifier

  • 84924871389

Digital Object Identifier (DOI)

  • 10.7326/ACPJC-2015-162-6-013

PubMed ID

  • 25775344

Additional Document Info

volume

  • 162

issue

  • 6